Cross-border paid plasma donation among injection drug users in two Mexico–U.S. border cities
- 30 September 2009
- journal article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 20 (5) , 409-412
- https://doi.org/10.1016/j.drugpo.2008.12.006
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mexico's Evolving HIV EpidemicJAMA, 2008
- Respondent-Driven Sampling of Injection Drug Users in Two U.S.–Mexico Border Cities: Recruitment Dynamics and Impact on Estimates of HIV and Syphilis PrevalenceJournal of Urban Health, 2006
- Detection of hepatitis A virus from clotting factors implicated as a source of HAV infection among haemophilia patients in KoreaEpidemiology and Infection, 2005
- Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range‐of‐motion limitationTransfusion, 2004
- Transmission Rates of Hepatitis C Virus by Different Batches of a Contaminated Anti‐D Immunoglobulin PreparationVox Sanguinis, 1999
- LAV/HTLV-III Seroconversion and Disease in Hemophiliacs Treated in FranceNew England Journal of Medicine, 1986
- SEROCONVERSION FOR HTLV-III SINCE 1980 IN BRITISH HAEMOPHILIACSThe Lancet, 1985
- DIFFERENTIAL PREVALENCE OF ANTIBODY TO AIDS-ASSOCIATED RETROVIRUS IN HAEMOPHILIACS TREATED WITH FACTOR VIII CONCENTRATE VERSUS CRYOPRECIPITATE: RECOVERY OF INFECTIOUS VIRUSThe Lancet, 1985
- HTLV-III SEROPOSITIVITY IN EUROPEAN HAEMOPHILIACS EXPOSED TO FACTOR VIII CONCENTRATE IMPORTED FROM THE USAThe Lancet, 1984
- Commercial factor VIII associated hepatitis, 1974–75, in the United Kingdom: a retrospective surveyEpidemiology and Infection, 1978